Bicycle Therapeutics

📍 Cambridge, United Kingdom🗓 Founded 2009👥 256 employees💰 Last funded 2019
Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. Bicycle is evaluating BT5528, a second-generation Bicycle Toxin Conjugate (BTC™) targeting EphA2; BT8009, a second-generation BTC targeting Nectin-4, a well-validated tumor antigen; and BT7480, a Bicycle TICA™ targeting Nectin-4 and agonizing CD137, in company-sponsored Phase I/II trials. In addition, BT1718, a BTC that targets MT1-MMP, is being investigated in an ongoing Phase I/IIa clinical trial sponsored by the Cancer Research UK Centre for Drug Development. Bicycle is headquartered in Cambridge, UK, with many key functions and members of its leadership team located in Cambridge, MA. For more information, visit bicycletherapeutics.com.
3
Total investors
0
Early stage
0
Mid stage
3
Late stage
2009
Founded
Investor geography3 countries
United States
1
United Kingdom
1
Singapore
1
Investor activity2015–2019 · investors recorded per year
201512017120191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Bicycle Therapeutics?
Bicycle Therapeutics has 3 investors on record on gritt.io and 3 late-stage investors.
When did Bicycle Therapeutics last raise funding?
The most recent investment in Bicycle Therapeutics recorded on gritt.io was in 2019.
When was Bicycle Therapeutics founded?
Bicycle Therapeutics was founded in 2009.
What industry is Bicycle Therapeutics in?
Bicycle Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Bicycle Therapeutics based?
Bicycle Therapeutics is headquartered in Cambridge, United Kingdom.